Aaron D. Gilmour

Aaron D. Gilmour

Auto-generated profile, based on publicly available information

Aaron D. Gilmour

School of Physics, University of Sydney, Sydney, NSW 2006, Australia

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2023 in Applied Physics Reviews
Verified
Journal Article
Open access
PDF file
MZMasoud Zhianmanesh
Masoud Zhianmanesh
AGAaron Gilmour
Aaron Gilmour
MBMarcela M. M. Bilek
Marcela M. M. Bilek
Behnam AkhavanBehnam Akhavan
Behnam Akhavan
Surface biofunctionalization aims to create cell-instructive surfaces that control the behavior of cells and modulate cellular interactions by incorporating cell signaling moieties at the materials–biosystem interface. Despite advances in developing bioinert and biocompatible materials, blood clotting, inflammation, and cell death continue to be observed upon the contact of foreign materials with living tissues leading to the materials' rejection. Specific examples include the application of foreign materials in implantable devices (e.g., bone implants, antimicrobial surfaces, and cardiovascular stents), biosensors, drug delivery, and 3D-bioprinting. Biofunctionalization of materials to date has been predominantly realized using wet chemical approaches. However, the complexity of wet chemistry, toxicity of reactants, waste disposal issues, reaction time, poor reproducibility, and scalability drive a need for a paradigm shift from wet chemical approaches to dry methods of surface biofunctionalization. Plasma-based technologies that enable covalent surface immobilization of biomolecules have emerged as dry, reagent-free, and single-step alternatives for surface biofunctionalization. This review commences by highlighting the need for bioinstructive surfaces and coatings for various biomedical applications such as bone implants, antimicrobial surfaces, biosensors, and 3D-bioprinted structures, followed by a brief review of wet chemical approaches for developing biofunctionalized surfaces and biomimetic devices. We then provide a comprehensive review of the development of plasma-based technologies for biofunctionalization, highlighting the plasma–surface interactions and underpinning mechanisms of biomolecule immobilization.

15 February 2017 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
JGJosef Goding
Josef Goding
AGAaron Gilmour
Aaron Gilmour
PMPenny Martens
Penny Martens
LPLaura Poole‐Warren
Laura Poole‐Warren
Rylie A.  GreenRylie A. Green
Rylie A. Green

11 September 2017 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
JGJosef A. Goding
Josef A. Goding
AGAaron D. Gilmour
Aaron D. Gilmour
UAUlises A. Aregueta‐Robles
Ulises A. Aregueta‐Robles
EHErol A. Hasan
Erol A. Hasan
Rylie A.  GreenRylie A. Green
Rylie A. Green

11 January 2018 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
NSNaomi A. Staples
Naomi A. Staples
JGJosef A. Goding
Josef A. Goding
AGAaron D. Gilmour
Aaron D. Gilmour
KAKirill Y. Aristovich
Kirill Y. Aristovich
PBPhillip Byrnes-Preston
Phillip Byrnes-Preston
Rylie A.  GreenRylie A. Green
Rylie A. Green
Nerve block waveforms require the passage of large amounts of electrical energy at the neural interface for extended periods of time. It is desirable that such waveforms be applied chronically, consistent with the treatment of protracted immune conditions, however current metal electrode technologies are limited in their capacity to safely deliver ongoing stable blocking waveforms. Conductive hydrogel (CH) electrode coatings have been shown to improve the performance of conventional bionic devices, which use considerably lower amounts of energy than conventional metal electrodes to replace or augment sensory neuron function. In this study the application of CH materials was explored, using both a commercially available platinum iridium (PtIr) cuff electrode array and a novel low-cost stainless steel (SS) electrode array. The CH was able to significantly increase the electrochemical performance of both array types. The SS electrode coated with the CH was shown to be stable under continuous delivery of 2 mA square pulse waveforms at 40,000 Hz for 42 days. CH coatings have been shown as a beneficial electrode material compatible with long-term delivery of high current, high energy waveforms.

16 April 2015 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
JGJ. A. Goding
J. A. Goding
AGA. D. Gilmour
A. D. Gilmour
PMPenny Martens
Penny Martens
LPL. A. Poole-Warren
L. A. Poole-Warren
Rylie A.  GreenRylie A. Green
Rylie A. Green
Biological responses to neural interfacing electrodes can be modulated via biofunctionalisation of conducting polymer (CP) coatings. This study investigated the use of small bioactive molecules with anti-inflammatory properties. Specifically, anionic dexamethasone phosphate (DP) and valproic acid (VA) were used to dope the CP poly(ethylenedioxythiophene) (PEDOT). The impact of DP and VA on material properties was explored both individually and together as a codoped system, compared to the conventional dopant p-toluenesulfonate (pTS). Electrical properties of DP and VA doped PEDOT were reduced in comparison to PEDOT/pTS, however co-doping with both DP and VA was shown to significantly improve the electroactivity of PEDOT in comparison the individually doped coatings. Similarly, while the individually doped PEDOT coatings were mechanically friable, the inclusion of both dopants during electropolymerisation was shown to attenuate this response. In a whole-blood model of inflammation all DP and VA doped CPs retained their bioactivity, causing a significant reduction in levels of the pro-inflammatory cytokine TNF-α. These studies demonstrated that small charged bioactive molecules are able act as dopants for CPs and that co-doping with ions of varied size and doping affinity may provide a means of addressing the limitations of large bulky bimolecular dopants.

1 June 2016 in Biomaterials
Verified
Journal Article
Closed access
AGA.D. Gilmour
A.D. Gilmour
AWA.J. Woolley
A.J. Woolley
LPL.A. Poole-Warren
L.A. Poole-Warren
CTC.E. Thomson
C.E. Thomson
RGR.A. Green
R.A. Green